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Purpose 
To identify the key set of glaucoma surgery outcome measures considered most 
important and practical to collect by glaucoma specialists. 
 
Methods 
102 glaucoma specialists (57 members of the UK and Eire Glaucoma Society (UKEGS) 
and 45 members of the European Glaucoma society (EGS)) took part in an Online Delphi 
exercise.  The RAND/UCLA appropriateness method was used analyse data from each 
round and generate a disagreement index. 
 
Results 
Participants agreed on 13 baseline data points and 12 outcomes that were considered 
important and practical to collect. For intraocular pressure (IOP) percentage reduction 
in IOP from baseline (last three IOP readings pre-op) and reduction below a specified 
target were considered important. For visual fields, change in a global visual field index 
e.g. MD and development of progression as assessed by linear regression were 
considered important. From a safety perspective, any visual loss resulting in a doubling 
of the minimal angle of resolution, loss of 5dB or more of visual field or development of 
advanced field loss (Hodapp Parrish Anderson Stage 4) were considered important. 
The importance of routinely using patient reported outcome measures (PROMs) was 
highlighted. Consensus suggested that outcomes of glaucoma treatments should be 
reported at one, five and ten years. 
 
Conclusions 
There was broad consensus on a minimum dataset for reporting the outcomes of 
glaucoma surgery and outcome measurement intervals. 
 
Keywords 
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INTRODUCTION 
Clinical audit is a mechanism to explore whether healthcare provision is in line with 
acceptable standards.  This allows patients and care providers to know whether their 
service is doing well or whether improvements are required.  Audit and its associated 
feedback mechanism is widely used as a strategy to improve professional practice.  
This has been an important aspect of care delivery in the UK for many years and is 
being more widely recognized as important in measurement of routine clinical 
outcomes (http://www.eugs.org/eng/outcomes_chair_action.asp) in glaucoma. 
Healthcare professionals modify their practice when given feedback indicating that their 
clinical practice is inconsistent with a desired target1 and consequently generating 
focus on providing high value care2. In glaucoma audit it is essential to understand how 
well individuals and organisations deliver clinical care.  This is important for both 
established treatment practices and for newly introduced novel treatments. 
There is currently no established defined audit data set for evaluating clinical outcomes 
from glaucoma treatments and consequently no bench mark based on a defined and 
accepted core audit data set thus making comparisons between services and 
individuals impossible and preventing meaningful and effective audit from being 
achieved 3.  
Audit of cataract surgery outcomes4 has led to effective benchmarking standards being 
established and in the UK the NHS has established a national program of audit to 
benchmark outcomes for routine clinical practise (https://www.hqip.org.uk/national-
programmes/a-z-of-nca/) 
The aim of this study was through a consensus driven process to develop a core set of 
clinical outcomes which clinicians felt were important, reflected routine clinical care and 
were practical and easy to collect. 
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METHODS 
A Delphi study, using a modified version of the Research ANd Development 
(RAND)/University of California Los Angeles (UCLA) appropriateness method5 was 
administered via Survey Monkey. Potential important audit outcomes for glaucoma 
were identified from the literature6,7. Panellists were asked to rate each potential 
outcome for importance for inclusion in a set of glaucoma surgery audit outcomes.  For 
each potential outcome a 9-point scale was used to assess importance: 1 to 3 (‘not 
important’); 4 to 6 (‘indeterminate’ or ‘equivocal’); and 7 to 9 (‘very important’). A free 
text field for each question was included to ensure we collected all opinions considered 
important by panellists.  
A survey link was sent to 189 members of the UK and Eire Glaucoma Society 
(UKEGS) (Fifteen of these could not be delivered, leaving a total of 174 recipients) and 
attendees of the 2015 closed European Glaucoma Society (EGS) meeting in Tampere, 
Finland (130 members). The survey remained open for seven weeks, with weekly 
reminders sent to those who failed to respond.  
Round One contained seven questions exploring consensus, including baseline 
characteristics, baseline IOP definition, treatment and safety outcomes, IOP and VF 
success measures and timing of outcomes evaluation. Round Two featured seven 
questions based on the refined outcomes of Round One and feedback from Round 
One panellists. The RAND/UCLA disagreement index was used to assess the degree 
of disagreement on rated items in both rounds5.  An index of less than 1 is interpreted 
as no evidence of disagreement on an item. Participation in subsequent rounds was 
open to those who participated in a previous round and we judged consensus as 
present following a round with no disagreement on any of the rated items. 
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RESULTS 
Sixty-four UKEGS members agreed to participate and responded. A further 38 EGS 
members agreed to participate and responded for a total of 102 participants. Seventy-
five percent of panellists had previously carried out an audit of glaucoma outcomes 
with 21% having used an electronic medical record to facilitate the process. In Round 
Two, 84 consented to take part of whom 60 responded (71%, 42 UKEGS 18 EGS).  
The median time spent answering the Round One questionnaire was six minutes and 
12 seconds and the Round Two questionnaire five minutes and 41 seconds.  
The baseline characteristics the panellists agreed were important to collect are outlined 
in Table 1.  
Disagreement index values were calculated separately for UKEGS and EGS 
responses – however they were no material differences in these values so the 
combined UKEGS/EGS DI responses are presented in the tables 
The IOP value that should be used as the baseline was further explored in Round One 
(Table 2). There was broad agreement that selecting a baseline IOP is difficult, it would 
be useful to report both peak IOP off treatment and the mean of the last 3 IOP values 
before planned intervention on any topical medications (not diamox). 
Table 3 lists what follow-up data was considered important and practical to collect, 16 
outcome domains were ranked all of which were considered important except four.  
 
Safety outcomes were explored in more detail.  A loss of 3 lines of logMAR acuity was 
considered an important safety outcome by 84% of panellists with loss of perception of 
light suggested by 27% of panellists. Postoperative hypotony was also suggested in 
Round One and ranked in Round Two but there was disagreement between the groups 
as to whether this was an important safety outcome (median all 7, UK 8, EGS 5 – no 
disagreement all / UKEGS, EGS disagreement index 1.03).   
Further evaluation of the importance of different visual field outcomes was undertaken 
in Round One and is shown in table 4 
Panellists were asked which visual field parameters should be used to evaluate the 
success of treatments, a majority suggested that visual field outcomes should be 
measured in terms of both change in a global index and progression judged by linear 
regression. Interestingly there appeared to be a difference in emphasis here with UK 
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respondents favouring global measurement and EGS respondents favouring linear 
regression analysis.  Two further visual field criteria were suggested for consideration 
by panellists in Round One and subsequently rated in Round Two: The loss of visual 
field by a fixed amount e.g. 5dB and the loss of visual field to a fixed level e.g. Hodapp 
Parrish Anderson criteria for advanced field loss (stage 4). Both were considered 
important visual field outcomes (median score for both items all 7, UKEGS 7, EGS 7 – 
no disagreement).  
Success measures for IOP reduction were explored. The most popular overall measure 
was a percentage reduction from pre-treatment values followed by reduction to a 
clinician defined target IOP (Table 4).  
Table 5 shows the follow-up time points important for outcome measurements to be 
collected.  Twelve months and 5 years were the most popular choices.  A further two 
time points were suggested for Round Two: 10 years (median all 7, UK 7, EGS 8 – no 
disagreement) and the last visit prior to death (median all 6, UK 6, EGS 7 – no 
disagreement). 
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DISCUSSION 
Attempts are being made to use big data to improve the standard of care for patients 
with eye disease. Such projects work best if there are nationally or internationally 
agreed data sets8 and attempts have been made to achieve this for research 
outcomes. 
Using a consensus approach to identifying the important measure for audit outcomes 
allows determination of what outcomes are most important or relevant to collect and 
ensures that important outcomes are not overlooked.  
This study identified 13 baseline characteristics that were considered important to 
collect. Establishing a baseline data set is important as this will be used to define the 
risk/complexity of the cases undertaken which will be used for establishing weighted 
outcomes once sufficient data has been collected to allow this analysis to be 
undertaken. 
Of the 12 treatment outcome measures identified as important many were perhaps 
unsurprising for a cohort of glaucoma specialists.  
Regarding IOP, agreement on what should be recorded as the baseline IOP was 
achieved albeit requiring several different values to establish and this may be 
inconvenient in clinical practice. For IOP outcomes % reduction was the most popular 
and this is helpful as this is an objective assessment of IOP as opposed to target 
pressure measurement which may be different between clinicians because of 
subjective considerations9 and may also allow potential for gaming of outcomes. IOP is 
a commonly used outcome measure in glaucoma trials and is considered a surrogate 
for glaucoma progression, with lower IOP resulting in less visual field progression. 
However it only measures a single dimension of glaucoma care and it is acknowledged 
that IOP is an inadequate outcome measure used alone.10   
Similarly for VF a consensus on measurement of VF outcomes is also helpful as 
multiple different measurement options exist for evaluating visual fields reported in 
clinical trials6 In this study panellists agreed on the easiest to collect data– global VF 
measures.  
OCT is an important method of assessing structural glaucoma progression11.  However, 
it was not identified as an important outcome measure in this study.  As part of the 
Delphi process respondents were asked to identify other measurements they thought 
should be included as outcome measures and despite this opportunity in each round, 
OCT was not considered one of these.   
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Several of the outcomes identified may be considered either bilateral (Visual 
impairment status, driving status, NEVFQ-25 vision related QoL, glaucoma related 
QoL) or generic health measurements such as generic QoL.  While these are helpful 
perhaps in measuring a patient’s glaucoma status as “a patient” they may not be 
helpful if reflecting the outcome of a particular intervention on “an eye” as the effects of 
this outcome will be diluted with influences from the fellow eye and general health 
condition.  The inclusion of these measurements by a clinician cohort may reflect a 
growing awareness of the importance of considering all aspects of QoL in our 
treatment of patients.  However these are not generally collected as routine data and 
therefore inclusion would add an extra burden to patients and resources if they were to 
be collected. 
The results suggest some consensus among experts that outcomes should be 
measured at 12 months, which would be generally considered at the end of the active 
phase of many surgery interventions and at 5 years which, may provide more 
meaningful data on the life-time outcomes of an intervention. 
One limitation of this study is that patients as the service users were not involved in the 
process of selecting the outcomes, which should be included in an audit of glaucoma 
care provision. This requires further investigation and these findings should be 
combined with the outcomes of clinician preferences to form a composite outcomes 
dataset. 
Although consensus was reached on many elements within this study, the existence of 
consensus from a Delphi process does not mean that the ‘correct’ answer has been 
found. The participants were opportunistically chosen through membership of the EGS 
and UKEGS – however, we consider that a meaningful range of expert views were 
captured across our 60 completing panel experts.  
Identification of important outcomes in cataract surgery has led to a valid, evidence 
based benchmarking process4 which is now used to define acceptable levels of 
posterior capsule rupture rates in the UK. 
We anticipate that the information developed in this research will prove helpful to those 
seeking to undertake audits of glaucoma surgery. Through identifying a minimal 
dataset the audit process will be simplified and maximum benefit achieved.  It is hoped 
that the results of collection of large amounts of audit data on glaucoma outcomes will 
not only allow benchmark setting but also risk stratification for outcomes measured. 
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